The IMMVAC INC. products are based on two proprietary technologies in a single vaccine.
The patented, genetically-engineered Gram-negative bacterin is comprised of the universal core antigen common to all Gram-negative bacteria.
The patented IMMUNE Plus® stimulates production of B and T lymphocytes, thereby enhancing an animals overall immunity to disease.
Fax (573) 874-7108
6080 Bass Lane
Columbia, MO 65201
Join our mailing list: